Related Experiment Videos
Response of CBA/N mice to human B cell activating factor
Cellular Immunology
|June 1, 1978
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Synergy between paclitaxel plus an exogenous methyl donor in the suppression of murine demyelinating diseases.
Multiple sclerosis (Houndmills, Basingstoke, England)·2007
Multiple sclerosis: an important role for post-translational modifications of myelin basic protein in pathogenesis.
Molecular & cellular proteomics : MCP·2003
Primary structure of equine myelin basic protein by mass spectrometry.
Archives of biochemistry and biophysics·2002
Peptidylarginine deiminase: a candidate factor in demyelinating disease.
Journal of neurochemistry·2002
Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination.
Multiple sclerosis (Houndmills, Basingstoke, England)·2002
Development of cecal volvulus after redo pancreas transplantation.
Journal of surgical case reports·2026
Primary Diffuse Large B-Cell Lymphoma of the External Auditory Canal with Extensive Local Extension: A Case Report and Literature Review.
Iranian journal of otorhinolaryngology·2026
Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy.
Research and practice in thrombosis and haemostasis·2026